- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 307/78 - Benzo [b] furansHydrogenated benzo [b] furans
Patent holdings for IPC class C07D 307/78
Total number of patents in this class: 127
10-year publication summary
|
7
|
6
|
6
|
9
|
2
|
5
|
5
|
10
|
7
|
3
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Merck Patent GmbH | 5873 |
5 |
| Daewoong Pharmaceutical Co., Ltd. | 321 |
5 |
| LG Chem, Ltd. | 17594 |
3 |
| AstraZeneca AB | 2928 |
3 |
| Green Cross Corporation | 197 |
3 |
| Taisho Pharmaceutical Co., Ltd. | 868 |
3 |
| Toyama Chemical Co., Ltd. | 102 |
3 |
| Sanofi | 4036 |
3 |
| Tactogen Inc | 37 |
3 |
| BASF SE | 20892 |
2 |
| Merck Sharp & Dohme Corp. | 2200 |
2 |
| Allergan, Inc. | 2356 |
2 |
| The Board of Trustees of the University of Illinois | 2685 |
2 |
| Dainippon Sumitomo Pharma Co., Ltd. | 195 |
2 |
| Kissei Pharmaceutical Co., Ltd. | 187 |
2 |
| The Scripps Research Institute | 1347 |
2 |
| Board of Regents of The University of Texas System, Austin | 2 |
2 |
| Autobahn Therapeutics, Inc. | 43 |
2 |
| Novartis AG | 10886 |
1 |
| Bristol-myers Squibb Company | 4879 |
1 |
| Other owners | 76 |